Co announces the publication of two important studies: Long-term outcome in pulmonary arterial hypertension patients with subcutaneous treprostinil; and Rapid Switch from intravenous epoprostenol to ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA ...

Research Triangle Park, NC and Silver Spring, MD United Therapeutics Corporation announced the FDA has issued an approvable letter for treprostinil sodium injection (Remodulin®) for the treatment of ...

A short induction of Remodulin® (treprostinil) injection allowed study subjects to reach double the typical doses of Orenitram® (treprostinil) extended-release tablets than patients who did not have a ...

Unfortunately, the vast majority of all of the patients, every single oral therapy out there approved is going to end up needing parenteral therapy and we want to be able to offer them something which ...